Interruptions in bladder cancer care during the COVID-19 public health emergency
-
Published:2023-12
Issue:
Volume:
Page:
-
ISSN:1078-1439
-
Container-title:Urologic Oncology: Seminars and Original Investigations
-
language:en
-
Short-container-title:Urologic Oncology: Seminars and Original Investigations
Author:
Gore John L.ORCID, Follmer Kristin, Reynolds Jason, Nash Michael, Anderson Christopher B., Catto James W.F., Chamie Karim, Daneshmand Siamak, Dickstein Rian, Garg Tullika, Gilbert Scott M., Guzzo Thomas J., Kamat Ashish M., Kates Max R., Lane Brian R., Lotan Yair, Mansour Ahmed M., Master Viraj A., Montgomery Jeffrey S., Morris David S., Nepple Kenneth G., O'Neil Brock B., Patel Sanjay, Pohar Kamal, Porten Sima P., Riggs Stephen B., Sankin Alexander, Scarpato Kristen R., Shore Neal D., Steinberg Gary D., Strope Seth A., Taylor Jennifer M., Comstock Bryan A., Kessler Larry G., Wolff Erika M., Smith Angela B.
Funder
Patient-Centered Outcomes Research Institute
Reference7 articles.
1. Patient and public involvement in the design and conduct of a large, pragmatic observational trial to investigate recurrent, high-risk non-muscle-invasive bladder cancer;Smith;Cancer,2022 2. Variation in initial US hospital responses to the COVID-19 pandemic;Mathews;Crit Care Med,2021 3. Cancer screening tests and cancer diagnoses during the COVID-19 pandemic;Bakouny;JAMA Oncol,2021 4. Delivery of cancer care in Ontario, Canada, during the first year of the COVID-19 pandemic;Walker;JAMA Netw Open,2022 5. An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs;Muka;eLife,2023
|
|